Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT04224064

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2025-02-12

158

Participants Needed

1

Research Sites

483 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main objective of this project is to identify a new non-invasive biological test for the diagnosis of LPS by measuring circulating serine levels. The current gold standard is the detection of Mdm2 amplification by the FISH.

CONDITIONS

Official Title

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Men or women older than 18 years
  • Patients undergoing surgery for localized WD-LPS or DD-LPS
  • Patients with local or distant relapse of WD-LPS or DD-LPS
  • Patients with deep adipocytic tumors greater than 5 cm suggestive of atypical lipomatous tumor
  • Patients willing to provide blood samples
  • Patients who have signed informed consent
  • Healthy subjects older than 18 years
  • Healthy subjects willing to provide blood samples
  • Healthy subjects who have signed informed consent
  • Healthy subjects matched by sex and age to LPS patient cohort
Not Eligible

You will not qualify if you...

  • Receiving neoadjuvant treatment for current cancer
  • Not affiliated with the French Social Protection System
  • Follow-up impossible due to psychological, social, geographic, or familial reasons
  • Psychiatric illness preventing informed consent or compliance
  • Having another cancer within 5 years except in situ breast carcinoma or basocellular carcinoma
  • Pregnant or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut du Cancer de Montpellier - Val d'Aurelle

Montpellier, France, 34298

Actively Recruiting

Loading map...

Research Team

J

Jean-Pierre BLEUSE, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here